14
1 Pediatric Placebo- controlled Trials from the European Experience Ethics of Placebo-controlled Trials in Children FDA Pediatric Advisory Sub- committee Bethesda, MD, USA 11-12 September 2000 Francis P. Crawley European Forum for Good Clinical Practice & Member, Ethics Working Group Confederation of European

1 Ethical Concerns in Pediatric Placebo-controlled Trials from the European Experience Ethics of Placebo-controlled Trials in Children FDA Pediatric Advisory

Embed Size (px)

Citation preview

Page 1: 1 Ethical Concerns in Pediatric Placebo-controlled Trials from the European Experience Ethics of Placebo-controlled Trials in Children FDA Pediatric Advisory

1

Ethical Concerns in Pediatric Placebo-controlled Trials from

the European ExperienceEthics of Placebo-controlled Trials in Children

FDA Pediatric Advisory Sub-committeeBethesda, MD, USA

11-12 September 2000

Francis P. CrawleyEuropean Forum for Good Clinical Practice

&Member, Ethics Working Group

Confederation of European Specialists in Paediatrics

Page 2: 1 Ethical Concerns in Pediatric Placebo-controlled Trials from the European Experience Ethics of Placebo-controlled Trials in Children FDA Pediatric Advisory

9

The Paediatrician’s (Physician’s) Concern

• The duty of care

• The standard of care

• The bonus pater familias

Page 3: 1 Ethical Concerns in Pediatric Placebo-controlled Trials from the European Experience Ethics of Placebo-controlled Trials in Children FDA Pediatric Advisory

10

The Child in the Controlled Trial

• ‘. . . it is in the interest of children to evaluate medicinal products with scientifically proven methods. A precondition is minimising distress and risk due to studies.’

R. Kurz, The Paediatrician’s Approach to the “Best Interests” of Children, Slov. Pediatr 2000 5: 10-13.

Page 4: 1 Ethical Concerns in Pediatric Placebo-controlled Trials from the European Experience Ethics of Placebo-controlled Trials in Children FDA Pediatric Advisory

1114

‘The Gold Standard’

‘. . . Properly controlled RCTs form the only scientifically valid tools.’

PP De Deyn, J.Pharm.Med. June 2000

Page 5: 1 Ethical Concerns in Pediatric Placebo-controlled Trials from the European Experience Ethics of Placebo-controlled Trials in Children FDA Pediatric Advisory

1216

‘Ethically Justified’

‘The optimal (and therefore often placebo-controlled and ethically founded) RCT meets the duties of benefiting society and increasing knowledge without jeopardizing the well-being of the experimental subjects.’

PP De Deyn, J.Pharm.Med. June 2000

Page 6: 1 Ethical Concerns in Pediatric Placebo-controlled Trials from the European Experience Ethics of Placebo-controlled Trials in Children FDA Pediatric Advisory

1317

Justification of Randomisation

• Scientific Equipoise

• Personal Equipoise

Page 7: 1 Ethical Concerns in Pediatric Placebo-controlled Trials from the European Experience Ethics of Placebo-controlled Trials in Children FDA Pediatric Advisory

1418

Scientific Equipoise

The medical community is genuinely uncertain as to which treatment is

best.

Page 8: 1 Ethical Concerns in Pediatric Placebo-controlled Trials from the European Experience Ethics of Placebo-controlled Trials in Children FDA Pediatric Advisory

1519

Personal Equipoise

The patient is herself in a situation of uncertainty as to which treatment is

best.

Page 9: 1 Ethical Concerns in Pediatric Placebo-controlled Trials from the European Experience Ethics of Placebo-controlled Trials in Children FDA Pediatric Advisory

1722

Risk & Benefit

‘Benefit and risk are ethical commodities determined normatively on the basis of empirically proven preparation [product] characteristics occurring with a certain probability.’

Wagner & Herrmann, Int. J. Pharm. Med. June 2000

Page 10: 1 Ethical Concerns in Pediatric Placebo-controlled Trials from the European Experience Ethics of Placebo-controlled Trials in Children FDA Pediatric Advisory

1823

Uncertainty in Science & Ethics

‘For the management of uncertainty, ethical principles are important decision-/action-guiding tools.’

Wagner & Herrmann, Int. J. Pharm. Med. June 2000

Page 11: 1 Ethical Concerns in Pediatric Placebo-controlled Trials from the European Experience Ethics of Placebo-controlled Trials in Children FDA Pediatric Advisory

19

A Question

Page 12: 1 Ethical Concerns in Pediatric Placebo-controlled Trials from the European Experience Ethics of Placebo-controlled Trials in Children FDA Pediatric Advisory

20

Are placebos and controls ever justified in paediatric research?

Yes

Both are permissible in some circumstances. Where their use is justified in adults the same may be true in children, subject to consent.

Page 13: 1 Ethical Concerns in Pediatric Placebo-controlled Trials from the European Experience Ethics of Placebo-controlled Trials in Children FDA Pediatric Advisory

21

Are placebos and controls ever justified in paediatric research?

NoNew treatments should always be tested against old

and there is no case for withholding established treatments from children even if the evidence for efficacy is thin. Furthermore, placebos mean deception and controls signify uncertainty of a kind to which children should not be exposed.

TL Chambers, ‘Seven Questions about Paediatric Research, Journal of the Royal Society of Medicine 2000, 93: 320-321.

Page 14: 1 Ethical Concerns in Pediatric Placebo-controlled Trials from the European Experience Ethics of Placebo-controlled Trials in Children FDA Pediatric Advisory

22

Conclusion

Paediatric placebo-controlled trials can only be justified when the design, enrollment, and conduct of such trials are such that they address the best interests of the child-participant with a view toward his/her health and a concern with his/her dignity.